Bayer Beats FCA Suit Over Off-Label Yaz Marketing
A Texas federal judge on Friday tossed a lawsuit alleging Bayer Schering Pharma AG defrauded Medicaid by touting off-label uses for contraceptive drugs Yasmin and Yaz, saying a supposed whistleblower was...To view the full article, register now.
Already a subscriber? Click here to view full article